Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05142384 · ClinicalTrials.gov registry record · NA

ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start

A NA study of Depression, sponsored by Oregon Research Institute.

Recruiting
Registry status
NA
Development phase
960
Enrollment target
1
Study location

NCT05142384: Recruiting NA study of Depression, sponsored by Oregon Research Institute.

NCT05142384 is a NA study of Depression that is actively recruiting participants, run by Oregon Research Institute. The registered enrollment target is 960 participants, above the 785-participant average among 679 other Depression trials with a reported enrollment target (22% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05142384, a NA study of Depression, is actively recruiting participants, sponsored by Oregon Research Institute.

RECRUITING
Registry status
NA
Development phase
960 participants
Enrollment target
1
Study location

Study Summary

Low income women of childbearing age are at increased risk for depression and often do not receive needed treatment. Investigators developed Mom-Net, an on-line cognitive behavioral treatment (CBT) for depression to address the needs of low income women of childbearing age. The intervention program also includes live coaching to help the mothers engage and learn the CBT material. Mom-Net has been shown to be highly effective in reducing depressive symptoms and improving parenting behavior and child adjustment, in earlier controlled trials. In this project the investigators are examining whether access to Mom-Net can be expanded by delivering it in Head Starts (HS). To address that broad question, the investigators will focus on two sets of scientific questions: 1. Implementation Questions: e.g., Can HS agencies deliver the program successfully; do HSs choose to sustain the program after the research project ends; what agency characteristics are associated with successful delivery of Mom-Net); 2. Effectiveness Questions: e.g., Does Mom-Net reduce maternal depression when delivered by Head Start agencies, with HS staff doing the coaching? Head Start agencies will be randomized to deliver either Mom-Net with the usual high-intensity coaching or with a low-intensity coaching alternative. Within each agency, depressed mothers will be randomized to receive either: 1) Mom-Net program; or 2) Treatment as Usual (TAU;) referral to community mental health providers). Mothers initially assigned to the TAU condition, will have the option of receiving Mom-Net at a later date. Mothers will participate in assessments of depressive symptoms, parenting behavior, and child adjustment at Time 1 (T1; prior to randomization); and Time 2 (T2; after the intervention period) and Time 3 (T3; one year after T1).

Primary Outcome

Well-established measure of maternal depression with 9 self-report items, each rated on a 0 (not at all) to 3 (nearly every day) scale; total score will be used; interpretation: scores of 5, 10, 15, and 20 represent mild, moderate, moderately severe,and severe depression, respectively. Total score will be used to examine change from baseline to subsequent assessments.

Conditions Studied

Interventions

  • BEHAVIORAL Mom-Net
  • COMBINATION_PRODUCT Treatment as Usual/Waitlist

Study Locations (1)

Oregon

  • Oregon Research Institute - Springfield

Trial Details

FieldValue
Enrollment Target 960 participants
Start Date 2022-12-01
Est. Completion 2027-03-31
Phase NA
Oregon Research Institute

62 total trials

What NCT05142384 shows while recruiting

NCT05142384 is an interventional study that assigns participants to a tested intervention. The registered 960 participants enrollment target is mid-sized for trials with a published cap, above the 785-participant average among 679 other Depression trials with a reported enrollment target (22% higher).

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Mom-Net is the first listed.

NCT05142384 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT05142384 about?

NCT05142384 is a clinical study titled "ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start". Low income women of childbearing age are at increased risk for depression and often do not receive needed treatment. Investigators developed Mom-Net, an on-line cognitive behavioral treatment (CBT) for depression to address the needs of low income women of childbearing age. The intervention program ...

What is the current status of trial NCT05142384?

This trial is currently recruiting. It is a NA study. The enrollment target is 960 participants. The study started on 2022-12-01. Estimated completion is 2027-03-31.

What conditions does trial NCT05142384 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT05142384?

The interventions under investigation include: Mom-Net (BEHAVIORAL), Treatment as Usual/Waitlist (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT05142384?

This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05142384 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05142384's enrollment target sits among peer trials

960 44th of 679 higher than 636 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04726241 · 960 participants · Phase 1

    The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • NCT05178498 · 960 participants

    Impact of Dietary Inflammatory Potential on Breast Cancer Risk

  • NCT05946629 · 960 participants · NA

    SELUTION 4 De Novo Small Vessel IDE Trial

  • NCT06764485 · 960 participants · Phase 3

    A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT05142384, the US trial registry maintained by the National Library of Medicine. NCT05142384 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.